270 results on '"Mitzner S"'
Search Results
2. Effect of blood plasma components from patients with hepatic encephalopathy on electrophysiological activity of primary frontal cortex networks in vitro
3. Ciprofloxacin reduces the risk of hemolytic uremic syndrome in patients with Escherichia coli O104:H4-associated diarrhea
4. Extracorporeal Liver Support: Albumin Removal vs. Albumin Regeneration
5. C-reactive protein increases myocardial damage after STEMI
6. A liver cell-based biosensor in patients with septic shock: results of a second prospective study: OP-123
7. Improvement in Central Nervous System Functions During Treatment of Liver Failure with Albumin Dialysis MARS—A Review of Clinical, Biochemical, and Electrophysiological Data
8. PLASMA EXCHANGE IN GLUCOCORTICOSTEROID-UNRESPONSIVE PATIENTS WITH CLINICALLY ISOLATED SYNDROME: O41 (T.8-4)
9. A New Method of Monitoring Blood Pressure and Cardiac Output in Chronic Dialysis Patients: O136 (EI0056)
10. A new device for screening hepatotoxicity: test results with the muscle relaxant rocuronium: OP-110
11. Extracorporeal cell therapy of patients with septic shock using human donor granulocytes: OP-087
12. 2230Results from the CAMI1 Study: selective CRP apheresis as a new treatment option in acute myocardial infarction
13. Targeted chemotherapy by intratumour injection of encapsulated cells engineered to produce CYP2B1, an ifosfamide activating cytochrome P450
14. Systemic long-term delivery of antibodies in immunocompetent animals using cellulose sulphate capsules containing antibody-producing cells
15. Results of a liver cells-based biosensor in patients with septic shock: OP109
16. Extracorporeal treatment of sepsis with granulocyte-based bioreactors: KL026
17. Protein-bound uremic toxins accumulate in the cerebric of rats with chronic renal failure and affect blood brain-barrier integrity in vitro
18. Extracorporeal immune cell support allows for acute regeneration in bacterial sepsis: OP68
19. ECONOMIC EVALUATION AND SURVIVAL ANALYSIS OF THE LIVER DIALYSIS SYSTEM MARS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE: P97
20. MANGANESE IMPAIRS AMMONIA DETOXIFICATION BY GLIA: P.410
21. NEUROTOXIC AFFECTS OF MANGANESE (II) IN IN VITRO CORTICAL NETWORKS: P.409
22. MITOCHONDRIAL PERMEABILITY TRANSITION IS NOT ESSENTIAL FOR CYTOTOXIC EFFECTS OF Mn2+ ON GLIA: P.411
23. Albumin dialysis MARS 2003: what evidence, how to proceed?
24. Amino acid dysbalance in liver failure is favourably influenced by recirculating albumin dialysis (MARS)
25. Albumin dialysis: single pass vs. recirculation (MARS)
26. Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem
27. Encapsulation by polyelectrolyte complex formation - a way to make hepatocyte cultures safe, efficient and on-line available
28. REDUCTION OF NITRIC OXIDE DISPLACING ALBUMIN BOUND TOXINS BY EXTRACORPOREAL LIVER SUPPORT - NEW THERAPY FOR HYPERDYNAMIC CIRCULATION?
29. REDUCTION OF PLASMA HEPATOTOXICITY IN CHOLESTATIC PATIENTS BY EXTRACORPOREAL LIVER SUPPORT
30. Computeraided multichannel videomicroscopie - a new tool for monitoring of cell functions and biocompatibility investigations
31. IMPACT OF THE MOLECULAR ADSORBENT RECIRCULATING SYSTEM (MARS) ON CLINICAL OUTCOME OF LIFE THREATENING HEPATIC FAILURE
32. REACTION OF NEURONAL NETWORKS IN VITRO TO ULTRAFILTRATES OF LIVER COMA PLASMA INFLUENCE OF MARS TREATMENTS
33. Molecular Adsorbent Recycling System (MARS): Clinical Results of a New Membrane-Based Blood Purification System for Bioartificial Liver Support
34. EuCliD – ein deutsches Hämodialyseregister
35. CYTOTOXICITY OF EXTRACORPOREAL BLOOD COMPARTMENTS AS A CONTROL PARAMETER FOR LIVER SUPPORT THERAPY
36. BIOARTIFICIAL PHAGOCYTOSIS ASSIST- IN VITRO RESULTS
37. ALBUMIN DIALYSIS IN HEPATORENAL SYNDROME
38. PROTEIN FACILITATED TRANSPORT OF TOXINS THROUGH AN IMMUNOLOGICAL BARRIER BETWEEN A BIOARTIFICIAL LIVER AND THE PATIENTS BLOOD
39. Neue Ansätze der tragbaren Heim-Hämodialyse
40. Opal, but not MARS improves patients albumin binding function measured by Electron Spin Resonance (ESR) in a prospective multicenter trial
41. Pharmacokinetics of ciprofloxacin and levofloxacin in patients with liver cirrhosis: influence of albumin dialysis by Molecular Adsorbent Recirculating System (MARS). Is a dosage adjustment necessary?
42. SP247CYTOKINE ADSORPTION IS A PROMISING TOOL FOR THERAPY OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS (HLH)
43. Alterationen der kornealen Nervenfasermorphologie bei Patienten mit einer terminalen Niereninsuffizienz
44. Newly developed cell purification method allowing storage of purified granulocyte concentrates for 72 Hours
45. Cell-based hepatotoxicity-testing of systemic antimycotics
46. Long-term treatment with montmorillonite-illite clay mineral reduces uremic toxins and vascular pathologies in rats with chronic renal failure
47. Results of a second prospective study: Liver-cells based biosensor in patients with septic shock
48. Human hepatocytes as a tool for hepatotoxicity-testing
49. Cell-based hepatotoxicity-testing of systemic antimycotics
50. FRI-506 - Opal, but not MARS improves patients albumin binding function measured by Electron Spin Resonance (ESR) in a prospective multicenter trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.